Source: Benzinga

OyaGen: OyaGen, Inc. announces a new publication for its COVID therapeutic in development and publication of related patents

PreMarket Prep Press Releases Analyst Ratings News Options ETFs Real Time Feed Public RSS Feeds Submit News Tips Blog Embeddable Finance Widgets & Tools Benzinga Catalyst Affiliate Program Contributor Portal Licensing & Syndication Sponsored Content Advertise With Us Lead Generation & SEO About Us Careers In The News Events Contact Us Terms & Conditions Do Not Sell My Personal Data/Privacy Policy Disclaimer Service Status Sitemap

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Harold Smith's photo - President & CEO of OyaGen

President & CEO

Harold Smith

CEO Approval Rating

73/100

Read more